Showing results (1071-1080 of 1,132) with videos related to

Sort By:
Pageof 114
Journal of Geriatric Oncology|February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in CanadaLauren Curry, Sunita Ghosh, Erica Arenovich, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2026
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-year Results From Phase 3 EMPOWER-Lung 3 Part 2 TrialAna Baramidze, Tamta Makharadze, Miranda Gogishvili, et al.
American Journal of Medical Genetics|May 31, 1997
6p24-22 region and major psychoses in the Eastern Quebec population. Le Groupe IREPM Maziade, L Bissonnette, E Rouillard, et al.
European Urology|July 27, 2023
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 StudyElizabeth R Plimack, Thomas Powles, Viktor Stus, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2015
Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIAAnne-Claire Duchez, Luc H Boudreau, Gajendra S Naika, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Marek Ziobro, et al.
Cancer Treatment and Research Communications|July 23, 2025
Peripheral blood cells as prognostic markers in patients with advanced non-small cell lung cancer treated with cemiplimab as monotherapy or in combination with chemotherapyRolando J Acosta, Debra A G McIntyre, Joseph C Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell deathDan Weng, Robyn Marty-Roix, Sandhya Ganesan, et al.
Cancers|February 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status PatientsNoa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, et al.
Pageof 114